Skip to main content
Novartis
language-selector-globe
Choose Location
language-selector-globeSlovenia
EnglishSlovenian
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Albania | English
Albania | Shqip
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
language-selector-globeSlovenia
EnglishSlovenian
Americas Asia Pacific Europe International Middle East & Africa
Albania | English
Albania | Shqip
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • O nas 
      • Novartis v Sloveniji 
      • Vodstvo Novartisa v Sloveniji 
      • Naša strategija 
      • Raznolikost, pravičnost in vključenost 
      • Ljudje in kultura 
      • Zdravila 
      • Kontakti 
      Znanstvenica z masko in rokavicami uporablja tablico v laboratoriju
      O nas
    • Bolniki in negovalci 
      • Novartisova zaveza bolnikom in negovalcem 
      • Neželeni učinki in reklamacije 
      • Bolezni 
      • Zdravila 
      Starejša bolnica in mlajša negovalka
      Bolniki in negovalci
    • Zdravstveni delavci 
      • Informacije za strokovno javnost 
      • Zdravila 
      • Zdravila v razvoju 
      • Neželeni učinki in reklamacije 
      • Klinične študije 
      Starejši gospod na pregledu pri zdravniku
      Zdravstveni delavci
    • Odgovorno poslovanje 
      • Etika, tveganje in skladnost 
      • Dostopnost 
      • Environmental Sustainability 
      • Global Health 
      • Ethical Behavior 
      • Okoljsko poročanje 
      Dve osebi, ki se držita za roke
      Odgovorno poslovanje
    • Novice 
      • Arhiv novic 
      • Zgodbe 
      • Kontakt za medije 
      Moški bere časopis
      Novice
    • Kariera 
      • Zaposlitev v Novartisu v Sloveniji 
      • Študentje in dijaki 
      • Kako delamo 
      • Dobro počutje 
      • Raznolikost, pravičnost in vključenost 
      • Meet the teams 
      • Personal Growth 
      • Early Talent 
      • Awards and Recognition 
      Trije strokovnjaki se pogovarjajo o poslu na sestanku v pisarni
      Kariera
    • BioCamp 
    Nasmejana znanstvenica v laboratorijski halji in zaščitnih očalih v laboratoriju
    Domov
  1. Domov
  2. Zaposlitev v Novartisu v Sloveniji
  3. Zaposlitev v Novartisu v Sloveniji
  • Sort by Sort ascending
  • Naziv delovnega mesta Sort ascending
  • Stran
  • Lokacija
  • Divizija
  • Področje
  • Functional Area
  • Datum objave
Naziv delovnega mesta Sort ascending Stran Lokacija Divizija Področje Functional Area Datum objave
Clinical Project Manager INSURGENTES Mehika Development Development Research & Development 14 Avgust 2026
Logistics Leader INSURGENTES Mehika International Product Supply Chain Technical Operations 14 Avgust 2026
Project Enablement & Effectiveness INSURGENTES Mehika US Marketing Research & Development 14 Avgust 2026
Senior Finance Scope Enablement Manager INSURGENTES Mehika US Marketing Trženje 14 Avgust 2026
Team Lead General Ledger and Reporting LaCan INSURGENTES Mehika Finance Finance Revizija in finance 14 Avgust 2026
Threat Detection & Response Senior Specialist INSURGENTES Mehika Operations Information Technology Informacijska tehnologija 12 Avgust 2026
HEOR Operational Study Manager (3 roles) INSURGENTES Mehika US Marketing Research & Development 11 Avgust 2026
Scrum Master DD&IT US&I AMERICAS INSURGENTES Mehika Operations Information Technology Informacijska tehnologija 06 Avgust 2026
Representante Senior de Ventas Inmunología - Guadalajara INSURGENTES Mehika International Sales Prodaja 06 Avgust 2026
Record to Report Manager RLT / LDC - temporary INSURGENTES Mehika Finance Finance Revizija in finance 06 Avgust 2026
Record to report Team Lead Product Cost and Accounting- RLT-LDC (Inventory Accounting & Reporting) – temporary INSURGENTES Mehika Finance Finance Revizija in finance 06 Avgust 2026
IT Business Partner for US & Americas INSURGENTES Mehika Operations Information Technology Informacijska tehnologija 05 Avgust 2026
Pricing Manager INSURGENTES Mehika International Sales Market Access 05 Avgust 2026
Financial Controls and Compliance US Senior Manager INSURGENTES Mehika Finance Other Revizija in finance 05 Avgust 2026
Manufacturing Specialist INSURGENTES Mehika Operations Production / Manufacturing Technical Operations 04 Avgust 2026
Manufacturing Execution System (MES) Specialist INSURGENTES Mehika Operations Production / Manufacturing Technical Operations 28 Julij 2026
IT Sr. Business Analyst - CDMO INSURGENTES Mehika Operations Information Technology Informacijska tehnologija 14 Julij 2026
Procurement Category Manager INSURGENTES Mehika Operations Purchasing & Sourcing Nabava 10 Julij 2026
Project controller INSURGENTES Mehika Operations Production / Manufacturing Technical Operations 22 Junij 2026
Procurement Manager Regional INSURGENTES Mehika Operations Purchasing & Sourcing Nabava 22 Junij 2026
Associate Manager, Scientific Writing INSURGENTES Mehika US Marketing Trženje 22 Junij 2026
Performance Analytics & GenAI Manager INSURGENTES Mehika International General Management Trženje 22 Junij 2026
Congress and Digital Channel Partner INSURGENTES Mehika US Information Technology Research & Development 17 Junij 2026
Audit and Compliance Specialist INSURGENTES Mehika Operations Production / Manufacturing Quality 11 Junij 2026
Medical Information Agent INSURGENTES Mehika US Marketing Research & Development 31 Marec 2026
News Archive Navigation Language
  • English
  • French
  • German
No matching countries found
Iskanje

Novartis v Sloveniji

Navigacija Novartis
  • Bolniki in negovalci
  • Zdravstveni delavci
  • Odgovorno poslovanje
  • Novice
  • Kariera
Novice
  • Arhiv novic
Naš nabor zdravil
  • Zdravila
  • Zdravila v razvoju
  • Neželeni učinki in reklamacije
Druge Novartisove spletne strani
  • Globalna stran
Footer Bottom
© 2026 Novartis d.o.o.
  • Politika zasebnosti
  • Pogoji uporabe
  • Nastavitve piškotkov
  • Zemljevid strani
  • Dostopnost
Pregled strani
Stran je namenjena globalni javnosti